Clinical Presentation, Course, and Risk Factors Associated with Mortality in a Severe Outbreak of COVID-19 in Rhode Island, USA, April-June 2020.

COVID-19 LTCF nursing homes pandemic

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
24 Dec 2020
Historique:
received: 07 11 2020
revised: 08 12 2020
accepted: 21 12 2020
entrez: 30 12 2020
pubmed: 31 12 2020
medline: 31 12 2020
Statut: epublish

Résumé

Long-term care facilities (LTCFs) have had a disproportionally high mortality rate due to COVID-19. We describe a rapidly escalating COVID-19 outbreak among 116 LTCF residents in Rhode Island, USA. Overall, 111 (95.6%) residents tested positive and, of these, 48 (43.2%) died. The most common comorbidities were hypertension (84.7%) and cardiovascular disease (84.7%). A small percentage (9%) of residents were asymptomatic, while 33.3% of residents were pre-symptomatic, with progression to symptoms within a median of three days following the positive test. While typical symptoms of fever (80.2%) and cough (43.2%) were prevalent, shortness of breath (14.4%) was rarely found despite common hypoxemia (95.5%). The majority of patients demonstrated atypical symptoms with the most common being loss of appetite (61.3%), lethargy (42.3%), diarrhea (37.8%), and fatigue (32.4%). Many residents had increased agitation (38.7%) and anxiety (5.4%), potentially due to the restriction measures or the underlying mental illness. The fever curve was characterized by an intermittent low-grade fever, often the first presenting symptom. Mortality was associated with a disease course beginning with a loss of appetite and lethargy, as well as one more often involving fever greater than 38 °C, loss of appetite, altered mental status, diarrhea, and respiratory distress. Interestingly, no differences in age or comorbidities were noted between survivors and non-survivors. Taking demographic factors into account, treatment with anticoagulation was still associated with reduced mortality (adjusted OR 0.16; 95% C.I. 0.06-0.39;

Identifiants

pubmed: 33374131
pii: pathogens10010008
doi: 10.3390/pathogens10010008
pmc: PMC7824344
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Am Med Dir Assoc. 2020 Jul;21(7):905-908
pubmed: 32674817
Sci Rep. 2020 Nov 30;10(1):20834
pubmed: 33257703
J Am Med Dir Assoc. 2020 Oct;21(10):1378-1383.e1
pubmed: 32981664
Clin Infect Dis. 2000 Jul;31(1):148-51
pubmed: 10913413
JAMA Netw Open. 2020 Jul 1;3(7):e2015957
pubmed: 32697325
Sustain Cities Soc. 2020 Nov;62:102390
pubmed: 32834937
Acta Neuropathol. 2015 Apr;129(4):493-509
pubmed: 25537401
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Clin Infect Dis. 2020 Jul 28;71(15):861-862
pubmed: 32201889
J Infect. 2020 Oct;81(4):647-679
pubmed: 32592704
J Am Geriatr Soc. 2020 Sep;68(9):1899-1906
pubmed: 32557542
Eur Geriatr Med. 2020 Dec;11(6):1085-1088
pubmed: 33025500
J Am Geriatr Soc. 2020 Aug;68(8):1647-1652
pubmed: 32633418
Eur Geriatr Med. 2020 Nov 27;:
pubmed: 33245505
Maturitas. 2020 Nov;141:46-52
pubmed: 33036702
JAMA. 2020 Sep 15;324(11):1103-1105
pubmed: 32790822
J Infect. 2020 Oct;81(4):621-624
pubmed: 32735893
Infect Control Hosp Epidemiol. 2020 Oct 26;:1-6
pubmed: 33100245
Clin Infect Dis. 2020 Dec 3;71(9):2311-2313
pubmed: 32628269
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
JAMA. 2020 Jul 14;324(2):123-125
pubmed: 32525535
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17513-17515
pubmed: 32632012
Emerg Infect Dis. 2020 Oct;26(10):2416-2419
pubmed: 32614768
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1300-1304
pubmed: 32941409
J Infect. 2020 Sep;81(3):411-419
pubmed: 32504743
Mayo Clin Proc. 2020 Nov;95(11):2467-2486
pubmed: 33153635
JAMA. 2020 Jul 7;324(1):23-24
pubmed: 32442303
J Am Med Dir Assoc. 2020 Dec;21(12):1767-1773.e1
pubmed: 33153910
Am J Health Syst Pharm. 2020 Nov 16;77(23):1957-1960
pubmed: 32780839
JAMA. 2020 Jul 7;324(1):25-26
pubmed: 32501504
J Am Med Dir Assoc. 2020 Dec;21(12):1791-1797.e1
pubmed: 33256958
Clin Infect Dis. 2020 Aug 28;:
pubmed: 32857130
Respir Med Case Rep. 2020;31:101186
pubmed: 32834989
J Clin Nurs. 2020 Aug;29(15-16):2758-2759
pubmed: 32281165

Auteurs

Eleftheria Atalla (E)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Raina Zhang (R)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Fadi Shehadeh (F)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Evangelia K Mylona (EK)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Maria Tsikala-Vafea (M)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Saisanjana Kalagara (S)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Laura Henseler (L)

Medicine and Long-Term Care Associates Llc., Cranston, RI 02920, USA.

Philip A Chan (PA)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Rhode Island Department of Health Division of Preparedness, Response, Infectious disease and Emergency Medical Services (PRIDEMS), Providence, RI 02908, USA.

Eleftherios Mylonakis (E)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Classifications MeSH